Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Duet BioTherapeutics is a clinical stage immuno-oncology company pioneering the development of bifunctional oligonucleotides to address “undruggable” targets such as STAT3. The company’s mission is to discover and develop therapeutic solutions that empower the human immune system to restore health, even when faced with seemingly intractable, treatment-resistant cancer. Duet integrates the management and clinical developm...
Duet BioTherapeutics is a clinical stage immuno-oncology company pioneering the development of bifunctional oligonucleotides to address “undruggable” targets such as STAT3. The company’s mission is to discover and develop therapeutic solutions that empower the human immune system to restore health, even when faced with seemingly intractable, treatment-resistant cancer. Duet integrates the management and clinical development of the immunotherapy assets of Scopus BioPharma and Olimmune, a company.

List your booth number for exhibitions, ask us